Advertisement
Screener

Starling Oncology, Inc. (DFPH) Increase (Decrease) in Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

Starling Oncology, Inc. Increase (Decrease) in Accrued Liabilities

Starling Oncology, Inc. (DFPH) reported Increase (Decrease) in Accrued Liabilities of $7.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06

  • Starling Oncology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $3.44M.
  • Starling Oncology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $3.92M, a 52.63% increase year-over-year.
  • Starling Oncology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$2.84M, a 160.93% decline year-over-year.
  • Starling Oncology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $127.00K, a 95.53% decline year-over-year.
  • Starling Oncology, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$448.00K, a 104.73% decline from fiscal 2024.
  • Starling Oncology, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $9.47M, a 182.13% increase from fiscal 2023.
  • Starling Oncology, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $3.36M, a 42.91% increase from fiscal 2022.
  • Starling Oncology, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $2.35M.
Period endIncrease (Decrease) in Accrued Liabilities 2 monthIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 3 month as first filedIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 6 month as first filedIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 9 month as first filedIncrease (Decrease) in Accrued Liabilities 12 monthIncrease (Decrease) in Accrued Liabilities 12 month as first filed
2026-06-30$3.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$7.35M
10-Q · filed 2026-08-06
$4.52M
derived: sum of 3 quarters · filed 2026-08-06
$4.64M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$3.92M
10-Q · filed 2026-05-07
$1.08M
derived: sum of 2 quarters · filed 2026-05-07
$1.21M
derived: sum of 3 quarters · filed 2026-05-07
$903.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$2.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$2.71M
derived: sum of 2 quarters · filed 2026-03-12
-$3.02M
derived: sum of 3 quarters · filed 2026-08-06
-$448.00K
10-K · filed 2026-03-12
2025-09-30$127.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$178.00K
derived: sum of 2 quarters · filed 2026-08-06
$2.39M
10-Q · filed 2025-11-13
$7.04M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$305.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$2.26M
10-Q · filed 2026-08-06
$6.92M
derived: sum of 3 quarters · filed 2026-08-06
$9.76M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$2.57M
10-Q · filed 2026-05-07
$7.22M
derived: sum of 2 quarters · filed 2026-05-07
$10.06M
derived: sum of 3 quarters · filed 2026-05-07
$6.67M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$4.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$7.50M
derived: sum of 2 quarters · filed 2026-03-12
$4.10M
derived: sum of 3 quarters · filed 2026-03-12
$9.47M
10-K · filed 2026-03-12
2024-09-30$2.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$553.00K
derived: sum of 2 quarters · filed 2025-11-13
$4.82M
10-Q · filed 2025-11-13
$7.59M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$3.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$1.98M
10-Q · filed 2025-08-13
$4.75M
derived: sum of 3 quarters · filed 2025-08-13
$3.98M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$5.37M
10-Q · filed 2025-05-14
$8.15M
derived: sum of 2 quarters · filed 2025-05-14
$7.38M
derived: sum of 3 quarters · filed 2025-05-14
$9.53M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$2.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
$2.01M
derived: sum of 2 quarters · filed 2025-03-26
$4.16M
derived: sum of 3 quarters · filed 2025-03-26
$3.36M
10-K · filed 2025-03-26
2023-09-30-$771.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$1.38M
derived: sum of 2 quarters · filed 2024-11-13
$579.00K
10-Q · filed 2024-11-13
$34.00K
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$2.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$1.35M
10-Q · filed 2024-08-13
$805.00K
derived: sum of 3 quarters · filed 2024-08-13
$1.14M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$805.00K
10-Q · filed 2024-05-14
-$1.35M
derived: sum of 2 quarters · filed 2024-05-14
-$1.02M
derived: sum of 3 quarters · filed 2024-05-14
$1.02M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$545.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
-$213.00K
derived: sum of 2 quarters · filed 2024-03-28
$1.82M
derived: sum of 3 quarters · filed 2024-03-28
$2.35M
10-K · filed 2024-03-28
2022-09-30$332.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$2.37M
derived: sum of 2 quarters · filed 2023-11-08
$2.89M
10-Q · filed 2023-11-08
-$1.62M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$2.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$2.56M
10-Q · filed 2023-08-09
-$1.95M
derived: sum of 3 quarters · filed 2023-08-09
-$2.01M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$526.00K
10-Q · filed 2023-05-10
-$3.99M
derived: sum of 2 quarters · filed 2023-05-10
-$4.04M
derived: sum of 3 quarters · filed 2023-05-10
-$2.92M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31-$4.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-$4.57M
derived: sum of 2 quarters · filed 2023-03-16
-$3.44M
derived: sum of 3 quarters · filed 2023-03-16
-$3.08M
10-K · filed 2023-03-16
2021-09-30-$55.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$1.07M
derived: sum of 2 quarters · filed 2022-11-09
$1.43M
10-Q · filed 2022-11-09
$2.58M
10-Q · filed 2021-11-08
$6.62M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$1.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$1.49M
10-Q · filed 2022-08-09
$1.47M
10-Q · filed 2021-08-16
$6.67M
derived: sum of 3 quarters · filed 2022-08-09
$6.72M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$358.00K
10-Q · filed 2022-05-10
$30.00K
10-Q · filed 2021-05-28
$5.54M
derived: sum of 2 quarters · filed 2022-05-10
$5.59M
derived: sum of 3 quarters · filed 2022-05-10
$5.57M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$5.18M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-11
$5.23M
derived: sum of 2 quarters · filed 2022-03-11
$5.21M
derived: sum of 3 quarters · filed 2022-03-11
$5.21M
10-K · filed 2022-03-11
$48.50K
10-K · filed 2021-03-30
2020-09-30$50.12K
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2021-12-14
$28.00K
derived: sum of 2 quarters · filed 2021-12-14
$26.50K
10-Q/A · filed 2021-12-14
2020-06-30-$22.12K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
-$23.62K
10-Q · filed 2021-08-16
2020-03-31-$1.50K
10-Q · filed 2021-05-28
2019-12-31$1.50K
10-K/A · filed 2021-12-14